<?xml version="1.0" encoding="UTF-8"?>
<drug type="small molecule" created="2017-06-23" updated="2019-12-02">
  <drugbank-id primary="true">DB13306</drugbank-id>
  <name>Chlorquinaldol</name>
  <description>Chlorquinaldol was used historically as a topical antiseptic under the trade name Sterosan.[F4549] It was marketed in the 1950s as an iodine-free alternative which was also unrelated to sulfa drugs or hormones. Chlorquinaldol is currently approved by the European Medicines Agency as a combination tablet with promestriene for the treatment of bacterial vaginosis.[F4552]</description>
  <cas-number>72-80-0</cas-number>
  <unii>D6VHC87LLS</unii>
  <average-mass>228.07</average-mass>
  <monoisotopic-mass>226.9904692</monoisotopic-mass>
  <state>solid</state>
  <groups>
    <group>approved</group>
  </groups>
  <general-references>
    <articles>
      <article>
        <ref-id>A177760</ref-id>
        <pubmed-id>28642751</pubmed-id>
        <citation>Bortolin M, Bidossi A, De Vecchi E, Avveniente M, Drago L: In vitro Antimicrobial Activity of Chlorquinaldol against Microorganisms Responsible for Skin and Soft Tissue Infections: Comparative Evaluation with Gentamicin and Fusidic Acid. Front Microbiol. 2017 Jun 8;8:1039. doi: 10.3389/fmicb.2017.01039. eCollection 2017.</citation>
      </article>
      <article>
        <ref-id>A177766</ref-id>
        <pubmed-id>478062</pubmed-id>
        <citation>Degen PH, Moppert J, Schmid K, Weirich EG: Percutaneous absorption of chlorquinaldol (Sterosan). Dermatologica. 1979;159(3):239-44.</citation>
      </article>
      <article>
        <ref-id>A177772</ref-id>
        <pubmed-id>24115839</pubmed-id>
        <citation>Prachayasittikul V, Prachayasittikul S, Ruchirawat S, Prachayasittikul V: 8-Hydroxyquinolines: a review of their metal chelating properties and medicinal applications. Drug Des Devel Ther. 2013 Oct 4;7:1157-78. doi: 10.2147/DDDT.S49763. eCollection 2013.</citation>
      </article>
      <article>
        <ref-id>A177775</ref-id>
        <pubmed-id>20435781</pubmed-id>
        <citation>Darby CM, Nathan CF: Killing of non-replicating Mycobacterium tuberculosis by 8-hydroxyquinoline. J Antimicrob Chemother. 2010 Jul;65(7):1424-7. doi: 10.1093/jac/dkq145. Epub 2010 Apr 30.</citation>
      </article>
    </articles>
    <textbooks/>
    <links/>
    <attachments>
      <attachment>
        <ref-id>F4549</ref-id>
        <title>Sterosan Marketing Article</title>
        <url>//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/549/original/Prescription_Pad_Sterosan_Marketing.pdf?1556641498</url>
      </attachment>
      <attachment>
        <ref-id>F4552</ref-id>
        <title>EMA Approved Product List Chlorquinaldol</title>
        <url>//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/552/original/EMA_Approvals_for_Chlorquinaldol.pdf?1556641531</url>
      </attachment>
    </attachments>
  </general-references>
  <synthesis-reference/>
  <indication>Chlorquinaldol was used historically as a topical antiseptic agent for skin infections.[F4549] It maintains use in European countries as a combination vaginal tablet with promestriene for use in the treatment of vaginal infections.[F4552]</indication>
  <pharmacodynamics>Chlorquinaldol is bacteriocidal in both gram positive and gram negative bacteria. It is more effective in targeting gram positive bacteria, particularly staphylococci.[A177760]</pharmacodynamics>
  <mechanism-of-action>The mechanism by which Chlorquinaldol exerts it's bacteriocidal effect is unknown. 8-hydroxyquinolines are known to be bidentate chelators of several metal ions which act as critical enzyme cofactors.[A177772] However, the addition of exogenous metal ions does not appear to alter the minimum inhibitory concentration for mycobacterium tuberculosis suggesting that the primary mechanism does not rely on chelation.[A177775]</mechanism-of-action>
  <toxicity>Oral LD&lt;sub&gt;50&lt;/sub&gt; (rat) - 660mg/kg</toxicity>
  <metabolism>98% of drug is converted to the sulfate form and renally excreted. [A177766]</metabolism>
  <absorption>There is a high degree of variability in the extent of absorption of topically applied chorquinaldol preparations.[A177766] It is reported to be between 4.2 and 23.5% of the applied dose. This is quite low compared to orally administered preparations which displayed 67.6% absorption in the same study.</absorption>
  <half-life/>
  <protein-binding/>
  <route-of-elimination>Chlorquinadol is primarily excreted in the urine as the sulfate form. [A177766] About 2% is excreted as the parent drug.</route-of-elimination>
  <volume-of-distribution/>
  <clearance/>
  <classification>
    <description>This compound belongs to the class of organic compounds known as chloroquinolines. These are compounds containing a quinoline moiety, which carries one or more chlorine atoms.</description>
    <direct-parent>Chloroquinolines</direct-parent>
    <kingdom>Organic compounds</kingdom>
    <superclass>Organoheterocyclic compounds</superclass>
    <class>Quinolines and derivatives</class>
    <subclass>Haloquinolines</subclass>
    <alternative-parent>8-hydroxyquinolines</alternative-parent>
    <alternative-parent>Aryl chlorides</alternative-parent>
    <alternative-parent>Azacyclic compounds</alternative-parent>
    <alternative-parent>Benzenoids</alternative-parent>
    <alternative-parent>Heteroaromatic compounds</alternative-parent>
    <alternative-parent>Hydrocarbon derivatives</alternative-parent>
    <alternative-parent>Methylpyridines</alternative-parent>
    <alternative-parent>Organochlorides</alternative-parent>
    <alternative-parent>Organonitrogen compounds</alternative-parent>
    <alternative-parent>Organooxygen compounds</alternative-parent>
    <alternative-parent>Organopnictogen compounds</alternative-parent>
    <substituent>8-hydroxyquinoline</substituent>
    <substituent>Aromatic heteropolycyclic compound</substituent>
    <substituent>Aryl chloride</substituent>
    <substituent>Aryl halide</substituent>
    <substituent>Azacycle</substituent>
    <substituent>Benzenoid</substituent>
    <substituent>Chloroquinoline</substituent>
    <substituent>Heteroaromatic compound</substituent>
    <substituent>Hydrocarbon derivative</substituent>
    <substituent>Methylpyridine</substituent>
    <substituent>Organic nitrogen compound</substituent>
    <substituent>Organic oxygen compound</substituent>
    <substituent>Organochloride</substituent>
    <substituent>Organohalogen compound</substituent>
    <substituent>Organonitrogen compound</substituent>
    <substituent>Organooxygen compound</substituent>
    <substituent>Organopnictogen compound</substituent>
    <substituent>Pyridine</substituent>
  </classification>
  <salts/>
  <synonyms>
    <synonym language="english" coder="">2-methyl-5,7-dichloro-8-hydroxyquinoline</synonym>
    <synonym language="english" coder="">5,7-dichloro-2-methyl-8-hydroxyquinoline</synonym>
    <synonym language="english" coder="">5,7-dichloro-2-methyl-8-quinolinol</synonym>
    <synonym language="english" coder="">5,7-dichloro-8-hydroxy-2-methylquinoline</synonym>
    <synonym language="english" coder="">5,7-dichloro-8-hydroxyquinaldine</synonym>
    <synonym language="english" coder="">5,7-dichloro-8-quinaldinol</synonym>
    <synonym language="english" coder="inn">Chlorquinaldol</synonym>
    <synonym language="latin" coder="">Chlorquinaldolum</synonym>
    <synonym language="spanish" coder="inn">Clorquinaldol</synonym>
  </synonyms>
  <products>
    <product>
      <name>T.R.U.E. Test Thin-Layer Rapid Use Patch Test</name>
      <labeller>SmartPractice Denmark ApS</labeller>
      <ndc-id/>
      <ndc-product-code>67334-0457</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2012-03-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Kit</dosage-form>
      <strength/>
      <route>Cutaneous</route>
      <fda-application-number>BLA103738</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
  </products>
  <international-brands/>
  <mixtures>
    <mixture>
      <name>T.R.U.E. Test Thin-Layer Rapid Use Patch Test</name>
      <ingredients>2-mercaptobenzothiazole + 2,2'-Dibenzothiazyl disulfide + 4-(Isopropylamino)diphenylamine + alpha-Amyl cinnamaldehyde + Bacitracin + Balsam of Peru + Benzocaine + Benzylparaben + Bisphenol A diglycidyl ether + Bromothalonil + Bronopol + Budesonide + Butylparaben + Chlorquinaldol + Cinchocaine + Cinnamaldehyde + Cinnamyl alcohol + Clioquinol + Cobalt chloride + Diazolidinylurea + Dichromate + Dipentamethylenethiuram disulfide + Diphenylguanidine + Disperse Blue 106 + Disulfiram + Ditiocarb Zinc + Ethyl hydroxybenzoate + Ethylenediamine + Eugenol + Evernia prunastri + Formaldehyde + Geraniol + Hydrocortisone butyrate + Hydroxycitronellal + Imidurea + Isoeugenol + Lanolin alcohols + Methylchloroisothiazolinone + Methylparaben + Morpholinylmercaptobenzothiazole + N-Cyclohexyl-N'-phenyl-1,4-phenylenediamine + N,N'-diphenyl-1,4-phenylenediamine + Neomycin + Nickel sulfate + p-Phenylenediamine + P-Tert-Butylphenol-Formaldehyde Resin (Low Molecular Weight) + Parthenolide + Propylparaben + Quaternium-15 + Rosin + Sodium aurotiosulfate + Tetracaine + Tetramethylthiuram monosulfide + Thimerosal + Thiohexam + Thiram + Tixocortol + Zinc Dibutyldithiocarbamate</ingredients>
    </mixture>
  </mixtures>
  <packagers/>
  <manufacturers/>
  <prices/>
  <categories>
    <category>
      <category>Anti-Infective Agents</category>
      <mesh-id>D000890</mesh-id>
    </category>
    <category>
      <category>Anti-Infective Agents, Local</category>
      <mesh-id>D000891</mesh-id>
    </category>
    <category>
      <category>Antiparasitic Products, Insecticides and Repellents</category>
      <mesh-id/>
    </category>
    <category>
      <category>Antiprotozoals</category>
      <mesh-id>D000981</mesh-id>
    </category>
    <category>
      <category>Antiseptics and Disinfectants</category>
      <mesh-id/>
    </category>
    <category>
      <category>Cell-mediated Immunity</category>
      <mesh-id/>
    </category>
    <category>
      <category>Chloroquinolinols</category>
      <mesh-id>D002739</mesh-id>
    </category>
    <category>
      <category>Dermatologicals</category>
      <mesh-id>D003879</mesh-id>
    </category>
    <category>
      <category>Genito Urinary System and Sex Hormones</category>
      <mesh-id/>
    </category>
    <category>
      <category>Gynecological Antiinfectives and Antiseptics</category>
      <mesh-id/>
    </category>
    <category>
      <category>Heterocyclic Compounds, Fused-Ring</category>
      <mesh-id>D000072471</mesh-id>
    </category>
    <category>
      <category>Hydroxyquinoline Derivatives</category>
      <mesh-id/>
    </category>
    <category>
      <category>Hydroxyquinolines</category>
      <mesh-id>D006912</mesh-id>
    </category>
    <category>
      <category>Increased Histamine Release</category>
      <mesh-id/>
    </category>
    <category>
      <category>Quinoline Derivatives</category>
      <mesh-id/>
    </category>
    <category>
      <category>Quinolines</category>
      <mesh-id>D011804</mesh-id>
    </category>
    <category>
      <category>Standardized Chemical Allergen</category>
      <mesh-id/>
    </category>
    <category>
      <category>Throat Preparations</category>
      <mesh-id/>
    </category>
  </categories>
  <affected-organisms>
    <affected-organism>Gram negative and gram positive bacteria</affected-organism>
  </affected-organisms>
  <dosages>
    <dosage>
      <form>Kit</form>
      <route>Cutaneous</route>
      <strength/>
    </dosage>
  </dosages>
  <atc-codes>
    <atc-code code="P01AA04">
      <level code="P01AA">Hydroxyquinoline derivatives</level>
      <level code="P01A">AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES</level>
      <level code="P01">ANTIPROTOZOALS</level>
      <level code="P">ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS</level>
    </atc-code>
    <atc-code code="R02AA11">
      <level code="R02AA">Antiseptics</level>
      <level code="R02A">THROAT PREPARATIONS</level>
      <level code="R02">THROAT PREPARATIONS</level>
      <level code="R">RESPIRATORY SYSTEM</level>
    </atc-code>
    <atc-code code="G01AC03">
      <level code="G01AC">Quinoline derivatives</level>
      <level code="G01A">ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS</level>
      <level code="G01">GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS</level>
      <level code="G">GENITO URINARY SYSTEM AND SEX HORMONES</level>
    </atc-code>
    <atc-code code="D08AH02">
      <level code="D08AH">Quinoline derivatives</level>
      <level code="D08A">ANTISEPTICS AND DISINFECTANTS</level>
      <level code="D08">ANTISEPTICS AND DISINFECTANTS</level>
      <level code="D">DERMATOLOGICALS</level>
    </atc-code>
  </atc-codes>
  <ahfs-codes/>
  <pdb-entries/>
  <msds>//s3-us-west-2.amazonaws.com/drugbank/msds/DB13306.pdf?1556641694</msds>
  <patents/>
  <food-interactions/>
  <drug-interactions/>
  <calculated-properties>
    <property>
      <kind>logP</kind>
      <value>3.82</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logS</kind>
      <value>-3.6</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>Water Solubility</kind>
      <value>5.38e-02 g/l</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logP</kind>
      <value>3.17</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>IUPAC Name</kind>
      <value>5,7-dichloro-2-methylquinolin-8-ol</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Traditional IUPAC Name</kind>
      <value>chlorquinaldol</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Weight</kind>
      <value>228.07</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Monoisotopic Weight</kind>
      <value>226.9904692</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>SMILES</kind>
      <value>CC1=NC2=C(C=C1)C(Cl)=CC(Cl)=C2O</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Formula</kind>
      <value>C10H7Cl2NO</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChI</kind>
      <value>InChI=1S/C10H7Cl2NO/c1-5-2-3-6-7(11)4-8(12)10(14)9(6)13-5/h2-4,14H,1H3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChIKey</kind>
      <value>GPTXWRGISTZRIO-UHFFFAOYSA-N</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polar Surface Area (PSA)</kind>
      <value>33.12</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Refractivity</kind>
      <value>56.16</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polarizability</kind>
      <value>21.62</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rotatable Bond Count</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Acceptor Count</kind>
      <value>2</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Donor Count</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest acidic)</kind>
      <value>6.99</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest basic)</kind>
      <value>4</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Physiological Charge</kind>
      <value>-1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Number of Rings</kind>
      <value>2</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Bioavailability</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rule of Five</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Ghose Filter</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>MDDR-Like Rule</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
  </calculated-properties>
  <experimental-properties>
    <property>
      <kind>Melting Point</kind>
      <value>108-112</value>
      <source>MSDS</source>
    </property>
  </experimental-properties>
  <external-identifiers>
    <external-identifier>
      <resource>ChEBI</resource>
      <identifier>74500</identifier>
    </external-identifier>
    <external-identifier>
      <resource>KEGG Drug</resource>
      <identifier>D07208</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChemSpider</resource>
      <identifier>6062</identifier>
    </external-identifier>
    <external-identifier>
      <resource>BindingDB</resource>
      <identifier>76302</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Wikipedia</resource>
      <identifier>Chlorquinaldol</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEMBL</resource>
      <identifier>CHEMBL224325</identifier>
    </external-identifier>
  </external-identifiers>
  <external-links/>
  <pathways/>
  <reactions>
    <reaction>
      <sequence>1</sequence>
      <left-element>
        <drugbank-id>DB13306</drugbank-id>
        <name>Chlorquinaldol</name>
      </left-element>
      <right-element>
        <drugbank-id>DBMET02452</drugbank-id>
        <name>Chorquinaldol Sulfate Metabolite</name>
      </right-element>
      <enzymes/>
    </reaction>
  </reactions>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets/>
  <enzymes/>
  <carriers/>
  <transporters/>
</drug>